Target intelligence / Profile preview

SH2B adapter protein 1 messenger RNA 3'-untranslated region (SH2B1 mRNA 3'-UTR)

Target
SH2B1 mRNA 3'-UTR
Molecular classification
Other
01

Overview

The SH2B adapter protein 1 (SH2B1) messenger RNA 3'-untranslated region (3'-UTR) is a critical regulatory segment that controls the expression of the SH2B1 protein, a key scaffold involved in leptin and insulin signaling pathways (UniProt Q9NRF2). This region contains multiple binding sites for microRNAs, such as miR-96 and miR-26, which post-transcriptionally repress SH2B1 expression, thereby contributing to the development of obesity and insulin resistance (PubMed 30144101). SH2B1 itself is essential for maintaining energy homeostasis, and its deficiency is linked to severe early-onset obesity and metabolic syndrome in humans (PubMed 20531471). As a therapeutic target, the SH2B1 3'-UTR is being investigated for RNA-based interventions, specifically antisense oligonucleotides (ASOs) that act as target site blockers to prevent microRNA-mediated silencing. By inhibiting these regulatory interactions, these experimental therapies aim to upregulate SH2B1 protein levels and restore sensitivity to metabolic hormones. This approach is particularly promising for treating genetic forms of obesity where SH2B1 levels are insufficient. However, challenges remain regarding the precise delivery of these agents to the hypothalamus and the potential for off-target effects within the transcriptome.

Other names
SH2B1 3'-UTRSH2B adapter protein 1 3'-UTRPSM 3'-UTRSH2B1 mRNA 3-prime untranslated region
02

Mechanism of action

Antisense-mediated inhibition of microRNA binding to increase protein translation

03

Biological functions

Signal transductionOther
04

Disease associations

Other
05

Safety considerations

Off-target RNA bindingCNS delivery challengesPotential for over-activation of growth pathways
06

Interacting drugs

Antisense oligonucleotides (experimental)

1 more in the full profile.

07

Biomarkers

SH2B1 expression levelsBody Mass Index (BMI)Glucose toleranceInsulin sensitivity

Beyond the preview

Go deeper on SH2B adapter protein 1 messenger RNA 3'-untranslated region (SH2B1 mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SH2B adapter protein 1 messenger RNA 3'-untranslated region (SH2B1 mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call